+ Watch CMXI
on My Watchlist
A biotechnology company that develops and licenses autologous cellular therapies, including Cytomedix's proprietary AutoloGel(tm) Process to produce a platelet rich plasma gel for the treatment of wounds.
I have to hand it to them, they fought the FDA all the way to a clearance for their AutoloGel. It has potential as a good product but it's a one product company that is barely on the market. I just can't see them holding on to a $3+ share price for long.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions